Evidence map›Paper›PMID 36430527›Full record

ArticleInternational journal of molecular sciences2022

Severe Obstructive Sleep Apnea Disrupts Vigilance-State-Dependent Metabolism.

Felix Schmidt, Nora Nowak, Patrick Baumgartner, Thomas Gaisl, Stefan Malesevic, Bettina Streckenbach, Noriane A Sievi, Esther I Schwarz, Renato Zenobi, Steven A Brown and 1 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Felix SchmidtFaculty of Medicine, University of Zurich, 8006 Zurich, Switzerland.ORCID 0000-0001-9878-1551
Nora NowakDepartment of Chemistry and Applied Biosciences, ETH Zurich, 8093 Zurich, Switzerland.
Patrick BaumgartnerFaculty of Medicine, University of Zurich, 8006 Zurich, Switzerland.
Thomas GaislFaculty of Medicine, University of Zurich, 8006 Zurich, Switzerland.ORCID 0000-0002-9017-6143
Stefan MalesevicFaculty of Medicine, University of Zurich, 8006 Zurich, Switzerland.
Bettina StreckenbachDepartment of Chemistry and Applied Biosciences, ETH Zurich, 8093 Zurich, Switzerland.
Noriane A SieviDepartment of Pulmonology, University Hospital Zurich, 8091 Zurich, Switzerland.
Esther I SchwarzFaculty of Medicine, University of Zurich, 8006 Zurich, Switzerland.ORCID 0000-0001-8840-981X
Renato ZenobiDepartment of Chemistry and Applied Biosciences, ETH Zurich, 8093 Zurich, Switzerland.
Steven A BrownInstitute of Pharmacology and Toxicology, University of Zurich, 8006 Zurich, Switzerland.
Malcolm KohlerFaculty of Medicine, University of Zurich, 8006 Zurich, Switzerland.
University of Zurich · CHETH Zurich · CHUniversity Hospital of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The direct pathophysiological effects of obstructive sleep apnea (OSA) have been well described. However, the systemic and metabolic consequences of OSA are less well understood. The aim of this secondary analysis was to translate recent findings in healthy subjects on vigilance-state-dependent metabolism into the context of OSA patients and answer the question of how symptomatic OSA influences metabolism and whether these changes might explain metabolic and cardiovascular consequences of OSA. Patients with suspected OSA were assigned according to their oxygen desaturation index (ODI) and Epworth Sleepiness Scale (ESS) score into symptomatic OSA and controls. Vigilance-state-dependent breath metabolites assessed by high-resolution mass spectrometry were used to test for a difference in both groups. In total, 44 patients were eligible, of whom 18 (40.9%) were assigned to the symptomatic OSA group. Symptomatic OSA patients with a median [25%, 75% quartiles] ODI of 40.5 [35.0, 58.8] events/h and an ESS of 14.0 [11.2, 15.8] showed moderate to strong evidence for differences in 18 vigilance-state-dependent breath compounds compared to controls. These identified metabolites are part of major metabolic pathways in carbohydrate, amino acid, and lipid metabolism. Thus, beyond hypoxia per se, we hypothesize that disturbed sleep in OSA patients persists as disturbed sleep-dependent metabolite levels during daytime.

Indexed as

Disorders of Excessive SomnolenceSleep Apnea, ObstructiveHumansOxygenSleepWakefulnessOxygenbreath analysismetabolomicsmitochondriaobstructive sleep apneasecondary electrospray ionizationsleep

Identifiers

PMID36430527
PMCPMC9694615
OpenAlexW4309027101

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.